Cleared Traditional

Arm Blood Pressure Monitor, model OB30, OB31, OB32, OB33 (K211532) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2022
Decision
246d
Days
Class 2
Risk

K211532 is an FDA 510(k) clearance for the Arm Blood Pressure Monitor, model OB30, OB31, OB32, OB33. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Yibin Junxin Electronics Technology Co., Ltd. (Yibin, CN). The FDA issued a Cleared decision on January 19, 2022 after a review of 246 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Yibin Junxin Electronics Technology Co., Ltd. devices

Submission Details

510(k) Number K211532 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 18, 2021
Decision Date January 19, 2022
Days to Decision 246 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
121d slower than avg
Panel avg: 125d · This submission: 246d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Share Info (Guangzhou) Medical Consultant , Ltd.
Cassie Lee

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 273
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K211532.
Wrist-type Fully Automatic Digital Blood Pressure Monitor
K213189 · Joytech Healthcare Co. , Ltd. · Mar 2022
Wrist Blood Pressure Monitor, models AOJ-35A, AOJ-35B, AOJ-35C, AOJ-35D, AOJ-35E
K213503 · Shenzhen AOJ Medical Technology Co., Ltd. · Feb 2022
RA-T59 Wrist blood pressure monitor
K212312 · Lotusnine Medical Limited · Jan 2022
Arm Blood Pressure Monitor
K212877 · Alicn Medical (Shenzhen), Inc. · Jan 2022
Arm-type Fully Automatic Digital Blood Pressure Monitor, Wrist-type Fully Automatic Digital Blood Pressure Monitor
K212115 · Joytech Healthcare Co. , Ltd. · Jan 2022
Microlife Wrist Watch Blood Pressure Monitor Model BP3GK1-4B
K211288 · Microlife Intellectual Property GmbH · Nov 2021